Can Vitamin K Reverse Brain Damage? Scientists Test New Compound

Scientists at the Shibaura Institute of Technology in Japan have engineered a hybrid vitamin K compound that may help reverse brain damage by stimulating neuron growth. The team, led by Associate Professor Yoshihisa Hirota and Professor Yoshitomo Suhara, combined vitamin K with retinoic acid—a derivative of vitamin A—to create 12 hybrid molecules. Testing revealed one compound, dubbed Novel VK, was three times more effective than natural vitamin K at converting neural stem cells into neurons in lab and animal studies. The study, published in *ACS Chemical Neuroscience* on July 3, 2025, found Novel VK activated mGluR1, a brain receptor linked to cell signaling and neuron growth. Molecular simulations showed the compound increased MK-4 (menaquinone-4) concentrations in cells more efficiently than natural vitamin K, suggesting it could enhance neuron regeneration. Researchers noted its ability to cross the blood-brain barrier, a critical requirement for potential brain-targeting therapies. While the findings are preliminary, the team believes the compound could advance regenerative medicine for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Previous research had shown natural vitamin K’s weak neuroprotective effects, but this modification significantly boosts its biological activity. The study was highlighted in science briefings as a promising step toward developing new treatments for brain cell damage. Further testing is needed to confirm safety and efficacy in humans, but the results suggest vitamin K derivatives could play a role in future therapies. The research was supported by the institute’s Department of Bioscience and Engineering, with plans to explore the compound’s potential in clinical applications.